Back to Search
Start Over
Can pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-O+) be added to standard treatment for resectable high-risk gastric cancer patients? A study protocol
- Source :
- Pleura and Peritoneum, Vol 6, Iss 4, Pp 151-154 (2021)
- Publication Year :
- 2021
- Publisher :
- De Gruyter, 2021.
-
Abstract
- Gastric cancer remains one of the most fatal cancers, despite an intensive treatment regime of chemotherapy–surgery–chemotherapy. Peritoneal metastatic disease is commonly diagnosed post treatment regime and once established, patients are likely to die in 3–9 months. Systemic chemotherapy does not increase survival for these patients due to the poor vascularisation of this area. We are proposing the addition of pressurised intraperitoneal aerosol chemotherapy (PIPAC) to the treatment regime for curative patients as a preventive measure to reduce the risk of peritoneal metastases occurring.
- Subjects :
- gastric
pipac
proof of concept
Medicine
Specialties of internal medicine
RC581-951
Subjects
Details
- Language :
- English
- ISSN :
- 2364768X and 20210132
- Volume :
- 6
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Pleura and Peritoneum
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.361853aad73e4594872367fe284f9a78
- Document Type :
- article
- Full Text :
- https://doi.org/10.1515/pp-2021-0132